1.
Br J Clin Pharmacol
; 83(10): 2330-2332, 2017 10.
Article
in English
| MEDLINE
| ID: mdl-28631271
Subject(s)
Anti-Asthmatic Agents/adverse effects , Eye Diseases/chemically induced , Myasthenia Gravis/chemically induced , Omalizumab/adverse effects , Anti-Asthmatic Agents/administration & dosage , Eye Diseases/physiopathology , Humans , Male , Middle Aged , Myasthenia Gravis/physiopathology , Omalizumab/administration & dosage
2.
Ned Tijdschr Geneeskd
; 156(22): A4464, 2012.
Article
in Dutch
| MEDLINE
| ID: mdl-22647228
ABSTRACT
BACKGROUND: Increasing numbers of patients are being treated with TNF-alpha inhibitors. Two patients in our outpatient clinic developed Merkel cell carcinoma during treatment with TNF alpha inhibitors. Since this is a very rare malignancy, this is a remarkable observation. CASE DESCRIPTION: A 70-year-old male with rheumatoid arthritis had been treated with etanercept for two years when he discovered a nodule on his elbow that started growing rapidly. It was diagnosed as Merkel cell carcinoma. Despite treatment, the patient died 2 years later. CONCLUSION: Merkel cell carcinoma is an aggressive malignancy with a clinically benign aspect. Patients treated with TNF-alpha inhibitors possibly have an increased risk of developing this malignancy.